Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

49.38
Delayed Data
As of Feb 05
 +0.79 / +1.63%
Today’s Change
45.69
Today|||52-Week Range
61.70
-6.51%
Year-to-Date

Today’s Trading

Previous close48.59
Today’s open48.60
Day’s range48.27 - 49.72
Volume16,883,010
Average volume (3 months)11,910,584
Market cap$137.9B
Dividend yield3.73%
Data as of 4:01pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+176.87%
Earnings growth (this year)+2.22%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-4.48%
P/E ratio13.1
Price/Sales3.95
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+1.35+0.50%
SNYSanofi-0.77-1.90%
BMYBristol-Myers Squibb-0.07-0.12%
NVSNovartis-0.73-0.97%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateApril 26, 2016
EPS forecast (this quarter)$0.85
Annual revenue (last year)$42.1B
Annual profit (last year)$11.9B
Net profit margin28.31%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers